Calcium dysregulation in atrial fibrillation: The role of CaMKII

Frontiers in Pharmacology

Volumn 5 MAR, Issue , 2014, Pages

  Heijman, Jordi ^a   Voigt, Niels ^a   Wehrens, Xander H T ^b   Dobrev, Dobromir ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Calcium; CaMKII; Ectopic activity; Reentry

Indexed keywords

CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL L TYPE; CALMODULIN; MYOSIN BINDING PROTEIN C; REACTIVE OXYGEN METABOLITE; SODIUM CALCIUM EXCHANGE PROTEIN; VOLTAGE GATED SODIUM CHANNEL;

ACTION POTENTIAL; ARRHYTHMOGENESIS; CALCIUM BINDING; CARDIOVASCULAR MORTALITY; COMORBIDITY; DOG; EXCITATION CONTRACTION COUPLING; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; MORBIDITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REENTRY ARRHYTHMIA; REVIEW; SUPRAVENTRICULAR TACHYCARDIA;

EID: 84897941229     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2014.00030     Document Type: Review

References (92)

1. Backs, J., Stein, P., Backs, T., Duncan, F. E., Grueter, C. E., McAnally, J., et al. (2010). The γ isoform of CaM kinase II controls mouse egg activation by regulating cell cycle resumption. Proc. Natl. Acad. Sci. U.S.A. 107, 81-86. doi: 10.1073/pnas.0912658106.
2. Bers, D. M. (2002). Cardiac excitation-contraction coupling. Nature 415, 198-205. doi: 10.1038/415198a.
3. Bootman, M. D., Smyrnias, I., Thul, R., Coombes, S., and Roderick, H. L. (2011). Atrial cardiomyocyte calcium signalling. Biochim. Biophys. Acta 1813, 922-934. doi: 10.1016/j.bbamcr.2011.01.030.
4. Brundel, B. J., Kampinga, H. H., and Henning, R. H. (2004). Calpain inhibition prevents pacing-induced cellular remodeling in a HL-1 myocyte model for atrial fibrillation. Cardiovasc. Res. 62, 521-528. doi: 10.1016/j.cardiores.2004.02.007.
5. Burashnikov, A., and Antzelevitch, C. (2003). Reinduction of atrial fibrillation immediately after termination of the arrhythmia is mediated by late phase 3 early afterdepolarization-induced triggered activity. Circulation 107, 2355-2360. doi: 10.1161/01.CIR.0000065578.00869.7C.
6. Camm, A. J., Lip, G. Y., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., et al. (2012). 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. developed with the special contribution of the European Heart Rhythm Association. Eur. Heart J. 33, 2719-2747. doi: 10.1093/eurheartj/ehs253.
7. Camm, J. (2012). Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits. Int. J. Cardiol. 155, 362-371. doi: 10.1016/j.ijcard.2011.06.012.
8. 2+ overload of cardiomyocytes by targeting CaMKIId. Biochem. Biophys. Res. Commun. 435, 720-726. doi: 10.1016/j.bbrc.2013.05.050.
9. 2+ leak promotes atrial fibrillation in mice. J. Clin. Invest. 119, 1940-1951. doi: 10.1172/JCI37059.
10. 2+ current downregulation in chronic human atrial fibrillation is associated with increased activity of protein phosphatases. Circulation 110, 2651-2657. doi: 10.1161/01.CIR.0000145659.80212.6A.
11. Chugh, S. S., Havmoeller, R., Narayanan, K., Singh, D., Rienstra, M., Benjamin, E. J., et al. (2013). Worldwide epidemiology of atrial fibrillation: a global burden of disease 2010 study. Circulation 129, 837-847. doi: 10.1161/CIRCULATIONAHA.113.005119.
12. 2+/calmodulin-dependent protein kinase II by basal autophosphorylation. J. Biol. Chem. 268, 7163-7170.
13. De Jong, A. M., Maass, A. H., Oberdorf-Maass, S. U., Van Veldhuisen, D. J., Van Gilst, W. H., and Van Gelder, I. C. (2011). Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc. Res. 89, 754-765. doi: 10.1093/cvr/cvq357.
14. Dibb, K. M., Clarke, J. D., Horn, M. A., Richards, M. A., Graham, H. K., Eisner, D. A., et al. (2009). Characterization of an extensive transverse tubular network in sheep atrial myocytes and its depletion in heart failure. Circ. Heart Fail. 2, 482-489. doi: 10.1161/CIRCHEARTFAILURE.109.852228.
15. Dobrev, D., Carlsson, L., and Nattel, S. (2012). Novel molecular targets for atrial fibrillation therapy. Nat. Rev. Drug Discov. 11, 275-291. doi: 10.1038/nrd3682.
16. Dobrev, D., Friedrich, A., Voigt, N., Jost, N., Wettwer, E., Christ, T., et al. (2005). The G protein-gated potassium current IK,ACh is constitutively active in patients with chronic atrial fibrillation. Circulation 112, 3697-3706. doi: 10.1161/CIRCULATIONAHA.105.575332.
17. Dobrev, D., and Nattel, S. (2008). Calcium handling abnormalities in atrial fibrillation as a target for innovative therapeutics. J. Cardiovasc. Pharmacol. 52, 293-299. doi: 10.1097/FJC.0b013e318171924d.
18. Dobrev, D., and Ravens, U. (2003). Remodeling of cardiomyocyte ion channels in human atrial fibrillation. Basic Res. Cardiol. 98, 137-148. doi: 10.1007/s00395-003-0409-8.
19. 2+ signaling. J. Mol. Cell. Cardiol. 46, 448-451. doi: 10.1016/j.yjmcc.2008.12.004.
20. Dobrev, D., Voigt, N., and Wehrens, X. H. (2011). The ryanodine receptor channel as a molecular motif in atrial fibrillation: pathophysiological and therapeutic implications. Cardiovasc. Res. 89, 734-743. doi: 10.1093/cvr/cvq324.
21. 2+ leak, and atrial fibrillation. Trends Cardiovasc. Med. 20, 30-34. doi: 10.1016/j.tcm.2010.03.004.
22. 2+ signals confer fibrogenesis in human atrial fibrillation. Circ. Res. 106, 992-1003. doi: 10.1161/CIRCRESAHA.109.206771.
23. Dublin, S., French, B., Glazer, N. L., Wiggins, K. L., Lumley, T., Psaty, B. M., et al. (2006). Risk of new-onset atrial fibrillation in relation to body mass index. Arch. Intern. Med. 166, 2322-2328. doi: 10.1001/archinte.166.21.2322.
24. 2+ handling in human chronic atrial fibrillation. Circulation 114, 670-680. doi: 10.1161/CIRCULATIONAHA.106.636845.
25. El-Haou, S., Balse, E., Neyroud, N., Dilanian, G., Gavillet, B., Abriel, H., et al. (2009). Kv4 potassium channels form a tripartite complex with the anchoring protein SAP97 and CaMKII in cardiac myocytes. Circ. Res. 104, 758-769. doi: 10.1161/CIRCRESAHA.108.191007.
26. Erickson, J. R., Joiner, M. L., Guan, X., Kutschke, W., Yang, J., Oddis, C. V., et al. (2008). A dynamic pathway for calcium-independent activation of CaMKII by methionine oxidation. Cell 133, 462-474. doi: 10.1016/j.cell.2008.02.048.
27. Erickson, J. R., Pereira, L., Wang, L., Han, G., Ferguson, A., Dao, K., et al. (2013). Diabetic hyperglycaemia activates CaMKII and arrhythmias by O-linked glycosylation. Nature 502, 372-376. doi: 10.1038/nature12537.
28. Gaborit, N., Steenman, M., Lamirault, G., Le Meur, N., Le Bouter, S., Lande, G., et al. (2005). Human atrial ion channel and transporter subunit gene-expression remodeling associated with valvular heart disease and atrial fibrillation. Circulation 112, 471-481. doi: 10.1161/CIRCULATIONAHA.104.506857.
29. Greiser, M., Neuberger, H. R., Harks, E., El-Armouche, A., Boknik, P., De Haan, S., et al. (2009). Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J. Mol. Cell. Cardiol. 46, 385-394. doi: 10.1016/j.yjmcc.2008.11.012.
30. Grimm, M., and Brown, J. H. (2010). Beta-adrenergic receptor signaling in the heart: role of CaMKII. J. Mol. Cell. Cardiol. 48, 322-330. doi: 10.1016/j.yjmcc.2009.10.016.
31. Gutierrez, D. A., Fernandez-Tenorio, M., Ogrodnik, J., and Niggli, E. (2013). NO-dependent CaMKII activation during β-adrenergic stimulation of cardiac muscle. Cardiovasc. Res. 100, 392-401. doi: 10.1093/cvr/cvt201.
32. Halt, A. R., Dallapiazza, R. F., Zhou, Y., Stein, I. S., Qian, H., Juntti, S., et al. (2012). CaMKII binding to GluN2B is critical during memory consolidation. EMBO J. 31, 1203-1216. doi: 10.1038/emboj.2011.482.
33. Harada, M., Luo, X., Qi, X. Y., Tadevosyan, A., Maguy, A., Ordog, B., et al. (2012). Transient receptor potential canonical-3 channel-dependent fibroblast regulation in atrial fibrillation. Circulation 126, 2051-2064. doi: 10.1161/CIRCULATIONAHA.112.121830.
34. He, J., Jiang, S., Li, F. L., Zhao, X. J., Chu, E. F., Sun, M. N., et al. (2013). MicroRNA-30b-5p is involved in the regulation of cardiac hypertrophy by targeting CaMKIId. J. Investig. Med. 61, 604-612. doi: 10.231/JIM.0b013e3182819ac6.
35. Heijman, J., Voigt, N., and Dobrev, D. (2013a). New directions in antiarrhythmic drug therapy for atrial fibrillation. Future Cardiol. 9, 71-88. doi: 10.2217/fca.12.78.
36. Heijman, J., Voigt, N., Nattel, S., and Dobrev, D. (2012). Calcium handling and atrial fibrillation. Wien. Med. Wochenschr. 162, 287-291. doi: 10.1007/s10354-012-0109-9.
37. Heijman, J., Voigt, N., Nattel, S., and Dobrev, D. (2014). Compendium: cellular and molecular electrophysiology of atrial fibrillation initiation, maintenance and progression. Circ. Res. doi: 10.1161/CIRCRESAHA.113.302226. [Epub ahead of print].
38. 2+ leak and re-entry? Acta Physiol. (Oxf.) 207, 208-211. doi: 10.1111/apha.12038.
39. 2+ spark mass. J. Mol. Cell. Cardiol. 48, 293-301. doi: 10.1016/j.yjmcc.2009.10.005.
40. Jayachandran, J. V., Sih, H. J., Winkle, W., Zipes, D. P., Hutchins, G. D., and Olgin, J. E. (2000). Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 101, 1185-1191. doi: 10.1161/01.CIR.101.10.1185.
41. King, J. H., Wickramarachchi, C., Kua, K., Du, Y., Jeevaratnam, K., Matthews, H. R., et al. (2013a). Loss of Nav1.5 expression and function in murine atria containing the RyR2-P2328S gain-of-function mutation. Cardiovasc. Res. 99, 751-759. doi: 10.1093/cvr/cvt141.
42. King, J. H., Zhang, Y., Lei, M., Grace, A. A., Huang, C. L., and Fraser, J. A. (2013b). Atrial arrhythmia, triggering events and conduction abnormalities in isolated murine RyR2-P2328S hearts. Acta Physiol. (Oxf.) 207, 308-323. doi: 10.1111/apha.12006.
43. 2+ influx contributes to Rac1-mediated production of reactive oxygen species in MLP-deficient mouse hearts. Biochem. Biophys. Res. Commun. 409, 108-113. doi: 10.1016/j.bbrc.2011.04.124.
44. Kumarswamy, R., and Thum, T. (2013). Non-coding RNAs in cardiac remodeling and heart failure. Circ. Res. 113, 676-689. doi: 10.1161/CIRCRESAHA.113.300226.
45. Lalani, G. G., Schricker, A. A., Clopton, P., Krummen, D. E., and Narayan, S. M. (2013). Frequency analysis of atrial action potential alternans: a sensitive clinical index of individual propensity to atrial fibrillation. Circ. Arrhythm. Electrophysiol. 6, 859-867. doi: 10.1161/CIRCEP.113.000204.
46. 2+ release in right atrial myocytes from experimental persistent atrial fibrillation. Circ. Res. 105, 876-885. doi: 10.1161/CIRCRESAHA.109.206276.
47. Li, N., Chiang, D. Y., Wang, S., Wang, Q., Sun, L., Voigt, N., et al. (2014). Ryanodine-receptor mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model. Circulation. doi: 10.1161/CIRCULATIONAHA.113.006611. [Epub ahead of print].
48. Li, N., Wang, T., Wang, W., Cutler, M. J., Wang, Q., Voigt, N., et al. (2012). Inhibition of CaMKII phosphorylation of RyR2 prevents induction of atrial fibrillation in FKBP12.6 knockout mice. Circ. Res. 110, 465-470. doi: 10.1161/CIRCRESAHA.111.253229.
49. Luo, X., Pan, Z., Shan, H., Xiao, J., Sun, X., Wang, N., et al. (2013). MicroRNA-26 governs profibrillatory inward-rectifier potassium current changes in atrial fibrillation. J. Clin. Invest. 123, 1939-1951. doi: 10.1172/JCI62185.
50. Makary, S., Voigt, N., Maguy, A., Wakili, R., Nishida, K., Harada, M., et al. (2011). Differential protein kinase C isoform regulation and increased constitutive activity of acetylcholine-regulated potassium channels in atrial remodeling. Circ. Res. 109, 1031-1043. doi: 10.1161/CIRCRESAHA.111.253120.
51. 2+/calmodulin kinase II after β1-adrenergic receptor stimulation. J. Cell Biol. 189, 573-587. doi: 10.1083/jcb.200911047.
52. Mani, S. K., Egan, E. A., Addy, B. K., Grimm, M., Kasiganesan, H., Thiyagarajan, T., et al. (2010). β-Adrenergic receptor stimulated Ncx1 upregulation is mediated via a CaMKII/AP-1 signaling pathway in adult cardiomyocytes. J. Mol. Cell. Cardiol. 48, 342-351. doi: 10.1016/j.yjmcc.2009.11.007.
53. 2+/calmodulin-sensitive TRPM7-like current in hepatoma and hepatocytes. Am. J. Physiol. Gastrointest. Liver Physiol. 297, G687-G694. doi: 10.1152/ajpgi.90683.2008.
54. Mishra, S., Gray, C. B., Miyamoto, S., Bers, D. M., and Brown, J. H. (2011). Location matters: clarifying the concept of nuclear and cytosolic CaMKII subtypes. Circ. Res. 109, 1354-1362. doi: 10.1161/CIRCRESAHA.111.248401.
55. Nattel, S., Burstein, B., and Dobrev, D. (2008). Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 1, 62-73. doi: 10.1161/CIRCEP.107.754564.
56. Nattel, S., and Dobrev, D. (2012). The multidimensional role of calcium in atrial fibrillation pathophysiology: mechanistic insights and therapeutic opportunities. Eur. Heart J. 33, 1870-1877. doi: 10.1093/eurheartj/ehs079.
57. 2+ levels in right atrial myocardium of patients with atrial fibrillation. Circ. Res. 106, 1134-1144. doi: 10.1161/CIRCRESAHA.109.203836.
58. 2+ release in the heart by activation of protein kinase Ce and calcium-calmodulin kinase II. J. Biol. Chem. 284, 1514-1522. doi: 10.1074/jbc.M806994200.
59. Parikh, A., Mantravadi, R., Kozhevnikov, D., Roche, M. A., Ye, Y., Owen, L. J., et al. (2012). Ranolazine stabilizes cardiac ryanodine receptors: a novel mechanism for the suppression of early afterdepolarization and torsades de pointes in long QT type 2. Heart Rhythm 9, 953-960. doi: 10.1016/j.hrthm.2012.01.010.
60. Park, H. W., Shen, M. J., Lin, S. F., Fishbein, M. C., Chen, L. S., and Chen, P. S. (2012). Neural mechanisms of atrial fibrillation. Curr. Opin. Cardiol. 27, 24-28. doi: 10.1097/HCO.0b013e32834dc4e8.
61. 2+ transient: an arrhythmia trigger within pulmonary veins. J. Am. Coll. Cardiol. 47, 1196-1206. doi: 10.1016/j.jacc.2005.12.023.
62. 2+ leak and arrhythmia. Circulation 127, 913-922. doi: 10.1161/CIRCULATIONAHA.12.148619.
63. 2+/calmodulin-dependent protein kinase II triggers atrial fibrillation. Circulation 128, 1748-1757. doi: 10.1161/CIRCULATIONAHA.113.003313.
64. Qi, X., Yeh, Y. H., Chartier, D., Xiao, L., Tsuji, Y., Brundel, B. J., et al. (2009). The calcium/calmodulin/kinase system and arrhythmogenic afterdepolarizations in bradycardia-related acquired long-QT syndrome. Circ. Arrhythm. Electrophysiol. 2, 295-304. doi: 10.1161/CIRCEP.108.815654.
65. Qi, X. Y., Yeh, Y. H., Xiao, L., Burstein, B., Maguy, A., Chartier, D., et al. (2008). Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. Circ. Res. 103, 845-854. doi: 10.1161/CIRCRESAHA.108.175463.
66. Richards, M. A., Clarke, J. D., Saravanan, P., Voigt, N., Dobrev, D., Eisner, D. A., et al. (2011). Transverse tubules are a common feature in large mammalian atrial myocytes including human. Am. J. Physiol. Heart Circ. Physiol. 301, H1996-H2005. doi: 10.1152/ajpheart.00284.2011.
67. Roderick, H. L., and Knollmann, B. C. (2013). Inositol 1,4,5-trisphosphate receptors: "exciting" players in cardiac excitation-contraction coupling? Circulation 128, 1273-1275. doi: 10.1161/CIRCULATIONAHA.113.005157.
68. Schlossarek, S., Mearini, G., and Carrier, L. (2011). Cardiac myosin-binding protein C in hypertrophic cardiomyopathy: mechanisms and therapeutic opportunities. J. Mol. Cell. Cardiol. 50, 613-620. doi: 10.1016/j.yjmcc.2011.01.014.
69. Schotten, U., Greiser, M., Benke, D., Buerkel, K., Ehrenteidt, B., Stellbrink, C., et al. (2002). Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort. Cardiovasc. Res. 53, 192-201. doi: 10.1016/S0008-6363(01)00453-9.
70. Shan, J., Xie, W., Betzenhauser, M., Reiken, S., Chen, B. X., Wronska, A., et al. (2012). Calcium leak through ryanodine receptors leads to atrial fibrillation in 3 mouse models of catecholaminergic polymorphic ventricular tachycardia. Circ. Res. 111, 708-717. doi: 10.1161/CIRCRESAHA.112.273342.
71. Sood, S., Chelu, M. G., Van Oort, R. J., Skapura, D., Santonastasi, M., Dobrev, D., et al. (2008). Intracellular calcium leak due to FKBP12.6 deficiency in mice facilitates the inducibility of atrial fibrillation. Heart Rhythm 5, 1047-1054. doi: 10.1016/j.hrthm.2008.03.030.
72. Swaminathan, P. D., Purohit, A., Hund, T. J., and Anderson, M. E. (2012). Calmodulin-dependent protein kinase II: linking heart failure and arrhythmias. Circ. Res. 110, 1661-1677. doi: 10.1161/CIRCRESAHA.111.243956.
73. 2+/calmodulin-dependent protein kinases II in human atrial myocytes. Circ. Res. 85, 810-819. doi: 10.1161/01.RES.85.9.810.
74. Trafford, A. W., Clarke, J. D., Richards, M. A., Eisner, D. A., and Dibb, K. M. (2013). Calcium signalling microdomains and the t-tubular system in atrial mycoytes: potential roles in cardiac disease and arrhythmias. Cardiovasc. Res. 98, 192-203. doi: 10.1093/cvr/cvt018.
75. Van Der Werf, C., Kannankeril, P. J., Sacher, F., Krahn, A. D., Viskin, S., Leenhardt, A., et al. (2011). Flecainide therapy reduces exercise-induced ventricular arrhythmias in patients with catecholaminergic polymorphic ventricular tachycardia. J. Am. Coll. Cardiol. 57, 2244-2254. doi: 10.1016/j.jacc.2011.01.026.
76. Vest, J. A., Wehrens, X. H., Reiken, S. R., Lehnart, S. E., Dobrev, D., Chandra, P., et al. (2005). Defective cardiac ryanodine receptor regulation during atrial fibrillation. Circulation 111, 2025-2032. doi: 10.1161/01.CIR.0000162461.67140.4C.
77. Voigt, N., Heijman, J., Wang, Q., Chiang, D. Y., Li, N., Karck, M., et al. (2014). Cellular and Molecular Mechanisms of Atrial Arrhythmogenesis in Patients With Paroxysmal Atrial Fibrillation. Circulation 129, 145-156. doi: 10.1161/CIRCULATIONAHA.113.006641.
78. 2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation. Circulation 125, 2059-2070. doi: 10.1161/CIRCULATIONAHA.111.067306.
79. Voigt, N., Maguy, A., Yeh, Y. H., Qi, X., Ravens, U., Dobrev, D., et al. (2008). Changes in IK,ACh single-channel activity with atrial tachycardia remodelling in canine atrial cardiomyocytes. Cardiovasc. Res. 77, 35-43. doi: 10.1093/cvr/cvm051.
80. Voigt, N., Rozmaritsa, N., Trausch, A., Zimniak, T., Christ, T., Wettwer, E., et al. (2010). Inhibition of IK,ACh current may contribute to clinical efficacy of class I and class III antiarrhythmic drugs in patients with atrial fibrillation. Naunyn Schmiedebergs Arch. Pharmacol. 381, 251-259. doi: 10.1007/s00210-009-0452-6.
81. + channels. J. Clin. Invest. 116, 3127-3138. doi: 10.1172/JCI26620.
82. Wagner, S., Hacker, E., Grandi, E., Weber, S. L., Dybkova, N., Sossalla, S., et al. (2009). Ca/calmodulin kinase II differentially modulates potassium currents. Circ. Arrhythm. Electrophysiol. 2, 285-294. doi: 10.1161/CIRCEP.108.842799.
83. Wagner, S., Ruff, H. M., Weber, S. L., Bellmann, S., Sowa, T., Schulte, T., et al. (2011). Reactive oxygen species-activated Ca/calmodulin kinase IId is required for late INa augmentation leading to cellular Na and Ca overload. Circ. Res. 108, 555-565. doi: 10.1161/CIRCRESAHA.110.221911.
84. Wakili, R., Voigt, N., Kaab, S., Dobrev, D., and Nattel, S. (2011). Recent advances in the molecular pathophysiology of atrial fibrillation. J. Clin. Invest. 121, 2955-2968. doi: 10.1172/JCI46315.
85. Wakili, R., Yeh, Y. H., Yan Qi, X., Greiser, M., Chartier, D., Nishida, K., et al. (2010). Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ. Arrhythm. Electrophysiol. 3, 530-541. doi: 10.1161/CIRCEP.109.933036.
86. Yang, Y., Guo, T., Oda, T., Chakraborty, A., Chen, L., Uchinoumi, H., et al. (2014). Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure. Circ. Res. 114, 295-306. doi: 10.1161/CIRCRESAHA.114.302857.
87. Yeh, Y. H., Wakili, R., Qi, X. Y., Chartier, D., Boknik, P., Kaab, S., et al. (2008). Calcium-handling abnormalities underlying atrial arrhythmogenesis and contractile dysfunction in dogs with congestive heart failure. Circ. Arrhythm. Electrophysiol. 1, 93-102. doi: 10.1161/CIRCEP.107.754788.
88. + channels SK1 and SK2 in human chronic atrial fibrillation. Life Sci. 90, 219-227. doi: 10.1016/j.lfs.2011.11.008.
89. Yue, L., Xie, J., and Nattel, S. (2011). Molecular determinants of cardiac fibroblast electrical function and therapeutic implications for atrial fibrillation. Cardiovasc. Res. 89, 744-753. doi: 10.1093/cvr/cvq329.
90. 2+ release. Nat. Med. 17, 1003-1009. doi: 10.1038/nm.2406.
91. + channels may contribute to electrical remodeling in human atrial fibrillation. Heart Rhythm 9, S319.
92. Zimetbaum, P. (2012). Antiarrhythmic drug therapy for atrial fibrillation. Circulation 125, 381-389. doi: 10.1161/CIRCULATIONAHA.111.019927.